Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin's Lymphoma - a population-based study

European Journal of Haematology

Volumn 87, Issue 3, 2011, Pages 208-216

  Glimelius, Ingrid ^a   Rubin, Jenny ^a   Rostgaard, Klaus ^b   Amini, Rose Marie ^a   Simonsson, Martin ^a   Sorensen, Karina M ^b   Smedby, Karin E ^c   Venge, Per ^a   Hjalgrim, Henrik ^b   Molin, Daniel ^a   Enblad, Gunilla ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b STATENS SERUM INSTITUT   (Denmark)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Asthma; Eosinophil; Eosinophil cationic protein; Hodgkin's lymphoma; Microenvironment

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PROTEIN X;

ADULT; AGED; ARTICLE; ASTHMA; CELL COUNT; CELL INFILTRATION; DNA POLYMORPHISM; EOSINOPHIL COUNT; EOSINOPHILIA; EPSTEIN BARR VIRUS; FEMALE; GENETIC RISK; GENOTYPE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MAST CELL; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE;

ASTHMA; CELL COUNT; DATA COLLECTION; EOSINOPHILS; FEMALE; GENOTYPE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; MALE; MAST CELLS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS;

EID: 84860389045     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2011.01652.x     Document Type: Article

References (33)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001.
2. de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006;6:24-37.
3. Hsi ED. Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment. Leuk Lymphoma 2008;49:1668-80.
4. Li H, Fan X, Houghton J. Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem 2007;101:805-15.
5. Bargou RC, Emmerich F, Krappmann D, et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997;100:2961-9.
6. Hoppe RT, Mauch PT, Armitage JO, Diehl V, Weiss LM. Hodgkin Lymphoma, 2nd edn. Philadelphia, USA: Lippincott Williams Wilkins, 2007.
7. Khan G. Epstein-Barr virus, cytokines, and inflammation: a cocktail for the pathogenesis of Hodgkin's lymphoma? Exp Hematol 2006;34:399-406.
8. Ahn KS, Aggarwal BB. Transcription factor NF-kappaB: a sensor for smoke and stress signals. Ann NY Acad Sci 2005;1056:218-33.
9. Pinto A, Aldinucci D, Gloghini A, et al. Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line. Blood 1996;88:3299-305.
10. Molin D, Fischer M, Xiang Z, Larsson U, Harvima I, Venge P, Nilsson K, Sundstrom C, Enblad G, Nilsson G. Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease. Br J Haematol 2001;114:616-23.
11. Enblad G, Sundstrom C, Glimelius B. Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis. Hematol Oncol 1993;11:187-93.
12. von Wasielewski R, Seth S, Franklin J, Fischer R, Hubner K, Hansmann ML, Diehl V, Georgii A. Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors. Blood 2000;95:1207-13.
13. Axdorph U, Porwit-MacDonald A, Grimfors G, Bjorkholm M. Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease. Leuk Lymphoma 2001;42:1055-65.
14. Keresztes K, Szollosi Z, Simon Z, Tarkanyi I, Nemes Z, Illes A. Retrospective analysis of the prognostic role of tissue eosinophil and mast cells in Hodgkin's lymphoma. Pathol Oncol Res 2007;13:237-42.
15. Molin D, Glimelius B, Sundstrom C, Venge P, Enblad G. The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease. Leuk Lymphoma 2001;42:457-65.
16. Rubin J, Zagai U, Blom K, Trulson A, Engstrom A, Venge P. The coding ECP 434(G>C) gene polymorphism determines the cytotoxicity of ECP but has minor effects on fibroblast-mediated gel contraction and no effect on RNase activity. J Immunol 2009;183:445-51.
17. Kariyawasam HH, Robinson DS. The role of eosinophils in airway tissue remodelling in asthma. Curr Opin Immunol 2007;19:681-6.
18. Ekstrom-Smedby K. Epidemiology and etiology of non-Hodgkin lymphoma - a review. Acta Oncol 2006;45:258-71.
19. Hjalgrim H, Smedby KE, Rostgaard K, et al. Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer Res 2007;67:2382-8.
20. Sorensen KM, Jespersgaard C, Vuust J, Hougaard D, Norgaard-Pedersen B, Andersen PS. Whole genome amplification on DNA from filter paper blood spot samples: an evaluation of selected systems. Genet Test 2007;11:65-71.
21. Teruya-Feldstein J, Jaffe ES, Burd PR, Kingma DW, Setsuda JE, Tosato G. Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia. Blood 1999;93:2463-70.
22. Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood 2002;99:4283-97.
23. Glimelius I, Edstrom A, Amini RM, Fischer M, Nilsson G, Sundstrom C, Enblad G, Molin D. IL-9 expression contributes to the cellular composition in Hodgkin lymphoma. Eur J Haematol 2006;76:278-83.
24. Aldinucci D, Lorenzon D, Cattaruzza L, Pinto A, Gloghini A, Carbone A, Colombatti A. Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions. Int J Cancer 2008;122:769-76.
25. Berkman N, Ohnona S, Chung FK, Breuer R. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24hours after allergen challenge. Am J Respir Cell Mol Biol 2001;24:682-7.
26. Rothenberg ME. Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues. Am J Respir Cell Mol Biol 1999;21:291-5.
27. Shi HZ, Humbles A, Gerard C, Jin Z, Weller PF. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest 2000;105:945-53.
28. Wagner L, Leiferman KM, Gleich GJ. Eosinophils. In: Peter Delves, ed. Encyclopedia of Life Sciences. Chichester: John Wiley and Sons Ltd., 2006: eLS: 1-9.
29. Domachowske JB, Dyer KD, Adams AG, Leto TL, Rosenberg HF. Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity. Nucleic Acids Res 1998;26:3358-63.
30. Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 2004;22:789-815.
31. Stenfeldt AL, Wenneras C. Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils. Immunology 2004;112:605-14.
32. Hjalgrim H, Rostgaard K, Johnson PC, et al. HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc Natl Acad Sci U S A 2010;107:6400-5.
33. Molin D, Edstrom A, Glimelius I, Glimelius B, Nilsson G, Sundstrom C, Enblad G. Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma. Br J Haematol 2002;119:122-4.